The Happenings of the Fertility Space in 2025

None of the organizations or individuals mentioned in this article reviewed nor had editorial control over its content.

Inside Reproductive Health launched a platform that includes information about almost every company on the industry side of the fertility field.

IRH says it is the start of the business intelligence hub for the fertility space. Clinic information, more company data, and market information from IRH’s Fertility Industry Reports, are expected to be added next year.

Some of the information summarized from the business intelligence hub includes:

Cercle announced a strategic partnership with Ivy Fertility, wherein Ivy adopted Cercle’s AI/data-platform across its clinic network to unify EMRs, enhance conversion, and elevate IVF outcomes.

Granata Bio acquired Oviva Therapeutics to expand into ovarian-aging therapeutics, including OVI-586 for improving ovarian response.

PatientFi accelerated its point-of-sale financing model for elective care, with CEO Todd Watts profiled for making patient payments simpler and more accessible.

BAIBYS announced its autonomous AI sperm-selection system received a CE mark, positioning the technology for clinical use.

Future Family launched a nationwide IVF insurance program (“baby or your money back”) and secured a $400M financing facility to scale access.

In her personal fertility journey, an influencer collaborated with CCRM in New York City to pursue egg freezing at age 39, bringing visibility to the access gaps Latinas face in assisted reproduction.

Artisan Medical Solutions highlighted EMR integration efforts with Cycle Clarity’s AI ultrasound platform to eliminate manual data entry and streamline communication.

Kindbody named industry veteran David Stern as CEO to lead its next stage of growth.

FutureLife expanded its Italian footprint via acquisition of Milano Fertility Clinic.

NEXUS acquired CRITEX GmbH (developer of MedITEX), extending its women’s-health software portfolio across the reproductive-medicine continuum.

Fellow received New York State approval for its lab and post-vasectomy semen-analysis kit, enabling broader availability.

Mind360 partners with fertility leaders including Fairfax Cryobank, California Cryobank, Illume Fertility, Inception, Ovation, Pinnacle Fertility, The Prelude Network, and Xytex Corporation to provide rapid, ASRM-compliant psychological evaluations that support donors, gestational carriers, and intended parents across global cryobank and clinic networks.

EVERSANA merged with Waltz Health to form a $6B company, with Mark Thierer taking the helm as CEO.

Future Family named Alden Romney as its new CEO — a healthcare executive with two decades of experience — to lead the company through its next phase of growth.

Kaleidoscope is addressing staffing shortages across fertility-clinic anesthesia by expanding its team of specialized CRNAs and prioritizing continuity of care to safeguard patient experience amid an aging workforce and tightening labor supply..

Nationwide IVF Service collaborates with an extensive network of fertility and life-science partners including CCRM Fertility, Kindbody, Ovation, Pinnacle Fertility, US Fertility, Hamilton Thorne, Thermo Fisher Scientific, and Carl Zeiss Microscopy, supporting clinics with integrated solutions spanning equipment, lab systems, and clinical operations.

Fertility Consultancy ApS launched IVFPro, a digital growth platform that guides fertility clinics through scaling operations, patient acquisition, and operational analytics across global markets.

Rescripted launched Clara, the first large language model built exclusively for women’s health, backed by founding partners like Brightside Health, Midi Health, Proov, and Gaia to harness shared content and scale trusted guidance across its platform.

The Prelude Network announced that 10 of its clinics were named among “America’s Best Fertility Clinics,” underscoring its growing reputation for excellence across its national footprint.

In a new study published in Nature Communications, Univfy’s center-specific machine learning models outperformed the U.S. national registry (SART) model in predicting IVF live birth, improving precision, calibration, and reclassification for diverse patient populations.

IVI RMA North America (which includes RMA, Boston IVF and TRIO) became the first in reproductive medicine to receive national Patient Safety Organization designation, underscoring its commitment to safety and quality across its clinic network.

Sunfish launched its “Gold IVF Success Program,” offering a money-back guarantee and unlimited embryo transfers to make IVF more financially accessible.

Shared Beginnings unveiled a refreshed brand identity to signal its growth from a regional donor program into a globally serving “medically-led” fertility platform, while retaining its mission of guaranteed outcomes and comprehensive donor services.

GeneScreen Counseling supports patients of CCRM, US Fertility, and Kindbody with tele-genetic counseling services that ensure informed decisions across preimplantation and prenatal testing.

Bird&Be expanded its reach by launching select products at Ulta Beauty, signaling a move to bring fertility-health tools into mainstream retail channels.

Doveras Fertility enrolled a diverse “Preconception Cohort I” of 600 individuals across 46 U.S. states through its digital health platform, delivering tailored lifestyle and behavioral interventions to populations often underserved in conventional fertility care.

As IVF labs face up to 30% specimen abandonment due to incomplete records or lack of traceability, CryoFuture’s integrated system helps clinics tag every vial with RFID, reconcile legacy inventory, and reduce compliance risk in long-term storage.

Meitheal is positioning itself to lower IVF attrition by offering high-quality generic fertility injectables and developing a biosimilar FSH pipeline, aiming to reduce cost barriers in fertility care.

Canadian fertility benefits plans, including those from insurers such as Sun Life and Manulife, have begun covering Future Fertility’s AI egg-quality assessments VIOLET™ and MAGENTA™, integrating them into employer-sponsored reproductive health programs.

LEVY Health is deploying AI-based clinical decision support systems (CDSS) for fertility clinics, enabling dynamic diagnostic recommendations, streamlined workflow, and predictive insights from patient histories and biomarkers.

In a comparative study of 177 IVF cycles, Cycle Clarity’s AI algorithm predicted mature oocyte counts with only a 0.71% average over-prediction error — more accurate than human REIs’ under-predictions of 4.85% — demonstrating its potential to streamline forecasting in embryology workflows.

BUNDL introduced a pioneering fertility financing model that consolidates treatment and medication costs into a single plan backed by a financial guarantee, aligning patient and clinic incentives across cycles.

MyEggBank is affiliated with the Center for Reproductive Medicine (CRM), which was spotlighted in Orlando Magazine’s “2024 Finest Physicians” issue as a leading fertility center in Florida.

HavenCryo introduced a long-term reproductive tissue cryopreservation solution offering enhanced security, geographic risk mitigation, and indefinite storage for eggs, sperm, and embryos as part of the Inception Fertility ecosystem.

Mandell’s Clinical Pharmacy serves leading fertility organizations including CCRM Fertility, First Fertility, Gaia, Maven Clinic, Northstar Fertility Group, Ovation, Posterity Health, Progyny, and Sunfish, supplying specialty reproductive medications and comprehensive patient-support information across the IVF continuum.

Innovation Fertility teamed up with Alife Health to deploy AI tools across its IVF clinics nationwide, aiming to enhance decision support and patient outcomes through data-driven insights.

Blue Cardinal Advisors provides strategic guidance to GeneScreen Genetics, advising the company’s leadership team as it advances genetic testing, counseling, and clinical support services in collaboration with partners such as RMA, CCRM, and Kindbody.

Conceive partnered with RMA of New York to integrate its fertility-support platform across the clinic’s Manhattan, Brooklyn, and Westchester locations, providing enhanced digital tools and 24/7 access to patients.

Cedro Strategy’s recent feature, “What Do IVF Patients Really Want?”, reframed the fertility industry’s focus from success rates to patient experience, calling for regulated standards in transparency, continuity, cost clarity, and digital access to make IVF care more accountable and humane.

MedTech For Solutions will provide Egg Fund’s new KinderHELOC financing option for fertility patients, enabling them to access credit lines from $3,000 to $100,000 to help cover treatment costs.

More highlights will be mentioned from Venna Health, Inception Fertility, Piedmont Reproductive Endocrinology Group (PREG), Pinnacle Fertility, The Fertility Partners, and Family Source Consultants.